Daisy Genomics raises $2.5 million to advance its revolutionary DNA and RNA sequencing technology for precision medicine, with plans to expand operations in Albuquerque’s growing bioscience sector.
An Albuquerque-based startup that recently secured $2.5 million in seed funding says it will use the money to continue its development of DNA and RNA sequencing technology used in precision medicine.
Daisy Genomics Inc. CEO Emily Milsovic said these … [1936 chars]
Source: Albuquerque Journal | Published: 2025-12-30T23:19:23Z
Credit: Albuquerque Journal
